Inspire Q2 2024 Earnings Report
Key Takeaways
Inspire Medical Systems reported a 30% year-over-year increase in revenue for the second quarter of 2024, reaching $195.9 million. The company achieved an 84.8% gross margin and generated $5.1 million in operating income, with earnings per share of $0.32. Due to these strong results, Inspire has increased its full-year revenue and earnings per share guidance.
Revenue increased by 30% year-over-year, reaching $195.9 million.
Gross margin was 84.8%.
Operating income was $5.1 million, with earnings per share of $0.32.
Full year revenue guidance increased to $788 million to $798 million, representing 26% to 28% growth.
Inspire
Inspire
Inspire Revenue by Geographic Location
Forward Guidance
Inspire is increasing its full year 2024 revenue guidance to between $788 million to $798 million, representing growth of 26% to 28%. The company is also increasing diluted net income per share guidance for the full year 2024 to between $0.60 to $0.80 per share.
Positive Outlook
- Revenue guidance increased to $788M - $798M (26-28% growth)
- Gross margin guidance maintained at 83% - 85%
- Diluted net income per share guidance increased to $0.60 - $0.80
- New U.S. medical center openings maintained at 52-56 per quarter
- New U.S. territories additions maintained at 12-14 per quarter
Revenue & Expenses
Visualization of income flow from segment revenue to net income